The Diagnostic value of serum levels of malondialdehyde (MDA) , superoxide dismutase (SOD) , glutathione peroxidase (GSH-Px) , IL-6, TNF-α, and IL-1β in preserving kidney function in diabetic renal cell carcinoma patients undergoing partial resection: A focus:

Jia Fu

doi:10.5937/jomb0-55290

Jia Fu 2Department of anesthesiology, Beijing Fengtai Hospital, Beijing, 100071, China

DOI: https://doi.org/10.5937/jomb0-55290

Keywords: TGF-β1/Smad signaling system; Dexmedetomidine; Diabetic nephropathy; Renal injury; Surgery, serum levels of malondialdehyde (MDA) , superoxide dismutase (SOD) , glutathione peroxidase (GSH-Px) , IL-6, TNF-α, and IL-1β

Abstract

Objective:Exploring how dexmedetomidine (DEX) affects renal damage in diabetic patients diagnosed with nephrocellular carcinoma who are receiving partial nephrectomy and Diagnostic value of serum levels of malondialdehyde (MDA) , superoxide dismutase (SOD) , glutathione peroxidase (GSH-Px) , IL-6, TNF-α, and IL-1β. Methods: Randomly selected 100 diabetic patients diagnosed with renal cell carcinoma, all treated at our facility from August 2022 to July 2024, to participate in the study.The patients received either 1.0 μg/kg of DEX or a corresponding volume of normal saline (as the control group) during their partial nephrectomy. Then assessed stress markers before, throughout, and following the surgical procedure to compare the outcomes between the two groups.Inflammatory indicators, TGF-β1/Smad pathway, renal function indicator levels and apoptosis of renal tissue cells. Results: Before administering anesthesia, there were no observable differences in stress levels, inflammatory markers, or TGF-β1/Smad signaling, as well as markers of kidney function between the two groups (P > 0.05). During and after the surgery, the study group exhibited lower serum levels of malondialdehyde (MDA) compared to the control group, while levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were higher (P < 0.05). Also, lower concentrations of IL-6, TNF-α, and IL-1β were recorded in the study group (P < 0.05). Similarly, there were reductions in the expressions of TGF-β1, Smad2 mRNA, and Smad3 mRNA (P < 0.05). Furthermore, the study group showed decreased levels of BUN, Scr, and CysC (P < 0.05). The incidence of renal tissue apoptosis as well as the expression levels of Cleaved Caspase-3 and Ki-67 were significantly reduced in the study group when compared with the control group (P < 0.05). Conclusion; DEX appears to protect against renal function and tissue damage by inhibiting the TGF-β1/Smad pathway and diminishing inflammatory responses.

References

References
Barata, P. C., & Rini, B. I. (2017). Treatment of renal cell carcinoma: Current status and future directions. CA: a cancer journal for clinicians, 67(6), 507–524. https://doi.org/10.3322/caac.21411
Bateman, R. M., Sharpe, M. D., Jagger, J. E., Ellis, C. G., Solé-Violán, J., López-Rodríguez, M., Herrera-Ramos, E., Ruíz-Hernández, J., Borderías, L., Horcajada, J., González-Quevedo, N., Rajas, O., Briones, M., Rodríguez de Castro, F., Rodríguez Gallego, C., Esen, F., Orhun, G., ErginOzcan, P., Senturk, E., Ugur Yilmaz, C., … Prandi, E. (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Critical care (London, England), 20(Suppl 2), 94.
https://doi.org/10.1186/s13054-016-1208-6
Bilotta, F., & Pugliese, F. (2020). The evolving clinical use of dexmedetomidine. Lancet (London, England), 396(10245), 145–147. https://doi.org/10.1016/S0140-6736(20)30902-8
Cole, J. B., &Florez, J. C. (2020). Genetics of diabetes mellitus and diabetes complications. Nature reviews. Nephrology, 16(7), 377–390. https://doi.org/10.1038/s41581-020-0278-5
Du, L., Chen, Y., Shi, J., Yu, X., Zhou, J., Wang, X., Xu, L., Liu, J., Gao, J., Gu, X., Wang, T., Yin, Z., Li, C., Yan, M., Wang, J., Yin, X., & Lu, Q. (2023). Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy. Metabolism: clinical and experimental, 144, 155376. https://doi.org/10.1016/j.metabol.2022.155376
Gwo‐Ping J,Tae Young Y (2023). Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study. European Heart Journal, 44 (Supplement_2), 0-0. https://doi.org/10.1093/eurheartj/ehad655.2544
He, G., He, Y., Ni, H., Wang, K., Zhu, Y., & Bao, Y. (2023). Dexmedetomidine attenuates neuroinflammation and microglia activation in LPS-stimulated BV2 microglia cells through targeting circ-Shank3/miR-140-3p/TLR4 axis. European journal of histochemistry : EJH, 67(3), 3766.
https://doi.org/10.4081/ejh.2023.3766
Hemsinli, D., Tumkaya, L., Ergene, S., Karakisi, S. O., Mercantepe, T., & Yilmaz, A. (2022). Dexmedetomidine attenuates pneumocyte apoptosis and inflammation induced by aortic ischemia-reperfusion injury. Clinical and experimental hypertension (New York, N.Y. : 1993), 44(7), 595–600. https://doi.org/10.1080/10641963.2022.2093893
Hu, M., Fan, J. Y., Zhou, X., Cao, G. W., & Tan, X. (2023). Zhonghualiuxingbingxue za zhi = Zhonghualiuxingbingxuezazhi, 44(4), 575–580. https://doi.org/10.3760/cma.j.cn112338-20220624-00558
Jiang, L., Wang, C., Tong, Y., Jiang, J., & Zhao, D. (2023). Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection. Journal of cancer research and clinical oncology, 149(13), 11873–11889. https://doi.org/10.1007/s00432-023-05072-8
Karagüzel, E. Ö., Arslan, F. C., Uysal, E. K., Demir, S., Aykut, D. S., Tat, M., & Karahan, S. C. (2019). Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder. Comprehensive psychiatry, 89, 61–66. https://doi.org/10.1016/j.comppsych.2018.11.013
Kwon, O., Lee, J. M., Park, J., Cho, M. C., Son, H., Jeong, H., Ryang, S. H., & Cho, S. Y. (2019). Influence of anesthesia methods on surgical outcomes and renal function in retrograde intrarenal stone surgery: a prospective, randomized controlled study. BMC anesthesiology, 19(1), 239.
https://doi.org/10.1186/s12871-019-0901-9
Lankadeva, Y. R., Ma, S., Iguchi, N., Evans, R. G., Hood, S. G., Farmer, D. G. S., Bailey, S. R., Bellomo, R., & May, C. N. (2019). Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury. Kidney international, 96(5), 1150–1161. https://doi.org/10.1016/j.kint.2019.06.013
Lawson, J. S., Syme, H. M., Wheeler-Jones, C. P. D., & Elliott, J. (2021). Investigation of the transforming growth factor-beta 1 signalling pathway as a possible link between hyperphosphataemia and renal fibrosis in feline chronic kidney disease. Veterinary journal (London, England : 1997), 267, 105582. https://doi.org/10.1016/j.tvjl.2020.105582
Li, X., Fan, Q. L., Ma, T. K., Liu, C., Shi, H., Sun, Y. Y., Wang, Y., Ding, D. X., Tang, A., Qin, Y., Yang, Q., Ding, H., Li, H. Y., & Fu, W. N. (2023). MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease. iScience, 26(9), 107609. https://doi.org/10.1016/j.isci.2023.107609
Li, Z. B., Li, G. C., & Qin, J. (2021). Dexmedetomidine Attenuates Lung Injury in Toxic Shock Rats by Inhibiting Inflammation and Autophagy. Archives of medical research, 52(3), 277–283.
https://doi.org/10.1016/j.arcmed.2020.11.001
Liao, W., Liang, P., Liu, B., Xu, Z., Zhang, L., Feng, M., Tang, Y., & Xu, A. (2020). MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1. Frontiers in physiology, 11, 1093. https://doi.org/10.3389/fphys.2020.01093
Liu, J., Zhang, Y., Tian, Y., Huang, W., Tong, N., & Fu, X. (2022). Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications. Theranostics, 12(3), 1342–1372.
https://doi.org/10.7150/thno.65778
Liu, Y. T., Liu, W., Wan, Z. H., Wang, X. Q., & Gu, F. X. (2020). Protective effect of dexmedetomidine against renal injury in diabetic nephropathy rats through inhibiting NF-κB pathway. European review for medical and pharmacological sciences, 24(22), 11865–11870.
https://doi.org/10.26355/eurrev_202011_23844
Liu, Y., Meng, L. L., Li, J. W., Jin, Y. S., & An, R. H. (2022). A Randomized Study on the Effect of Metformin Combined with Intensive-Exercise Diet Therapy on Glucose and Lipid Metabolism and Islet Function in Patients with Renal Cell Carcinoma and Diabetes. Disease markers, 2022, 7383745. https://doi.org/10.1155/2022/7383745
Manish S (2021). Diabetic Nephropathy and Diabetic Kidney Disease. Journal of diabetes mellitus, 11 (05), 359-377.
https://doi.org/10.4236/jdm.2021.115029
Maria do Carmo de Carvalho e Martins,AmandaSuellenn da Silva Santos Oliveira,Liriane Andressa Alves da Silva,MaísaGuimarães Silva Primo, & Vanessa Brito de Carvalho Lira (2022). Biological Indicators of Oxidative Stress [Malondialdehyde, Catalase, Glutathione Peroxidase, and Superoxide Dismutase] and Their Application in Nutrition. Biomarkers in disease, 0 (0), 833-856. https://doi.org/10.1007/978-3-031-07389-2_49
Nangaku M. (2020). Founding papers of current nephrology: from acute kidney injury to diabetic kidney disease. Kidney international, 98(1), 6–9. https://doi.org/10.1016/j.kint.2020.03.040
Pang, R., & Gu, D. (2021). Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway. Endocrine, metabolic &immune disorders drug targets, 21(10), 1905–1911. https://doi.org/10.2174/1871530320666201208110209
SongkaiL,HuanhuiZ,Chengda Z, ,Dan X,NaL,QierZ,WanjunL,Jia L, &Baiyun W. (2022). Dexmedetomidine preconditioning alleviates H2O2-induced oxidative stress and apoptosis in human umbilical vein endothelial cells via p38MAPK signaling pathway. Research Square (Research Square), 0 (0), 0-0. https://doi.org/10.21203/rs.3.rs-1290157/v1
Tang, F., Hao, Y., Zhang, X., & Qin, J. (2017). Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy. Drug design, development and therapy, 11, 2813–2826. https://doi.org/10.2147/DDDT.S143805
Tuttle, K. R., Jones, C. R., Daratha, K. B., Koyama, A. K., Nicholas, S. B., Alicic, R. Z., Duru, O. K., Neumiller, J. J., Norris, K. C., Ríos Burrows, N., &Pavkov, M. E. (2022). Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020. The New England journal of medicine, 387(15), 1430–1431. https://doi.org/10.1056/NEJMc2207018
Xie, Y., Wang, Q., He, Q., Yang, L., Meng, G., Geng, Y., & Yang, J. (2023). MiR-21 promotes renal injury in septic rats by regulating TGF-β1/Smad pathway. Minerva medica, 114(1), 123–124.
https://doi.org/10.23736/S0026-4806.20.06993-1
Yang, S., Zhang, T., Ge, Y., Cheng, Y., Yin, L., Pu, Y., Chen, Z., & Liang, G. (2023). Ferritinophagy Mediated by Oxidative Stress-Driven Mitochondrial Damage Is Involved in the Polystyrene Nanoparticles-Induced Ferroptosis of Lung Injury. ACS nano, 17(24), 24988–25004.
https://doi.org/10.1021/acsnano.3c07255
Yu, X. Y., Sun, Q., Zhang, Y. M., Zou, L., & Zhao, Y. Y. (2022). TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis. Frontiers in pharmacology, 13, 860588.
https://doi.org/10.3389/fphar.2022.860588
Yusupov, M., Privat-Maldonado, A., Cordeiro, R. M., Verswyvel, H., Shaw, P., Razzokov, J., Smits, E., & Bogaerts, A. (2021). Oxidative damage to hyaluronan-CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy. Redox biology, 43, 101968. https://doi.org/10.1016/j.redox.2021.101968
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020). Oxidative stress and diabetes: antioxidative strategies. Frontiers of medicine, 14(5), 583–600. https://doi.org/10.1007/s11684-019-0729-1
Zhang, S., Tang, J., Sun, C., Zhang, N., Ning, X., Li, X., & Wang, J. (2023). Dexmedetomidine attenuates hepatic ischemia-reperfusion injury-induced apoptosis via reducing oxidative stress and endoplasmic reticulum stress. International immunopharmacology, 117, 109959.
https://doi.org/10.1016/j.intimp.2023.109959